ask Ask a question
Favorite

BEND bovine endometrial epithelial cells (bEECs; ATCC® CRL-2398) were acquired from American Type Culture Collection. The cells were grown in a 1:1 mixture of Ham's F12 and Eagle's Minimal Essential medium (Gibco; Thermo Fisher Scientific, Inc.) with Earle's balanced salts with 1.5 mM L-glutamine (MilliporeSigma) adjusted to contain 1.5 g/l sodium bicarbonate (MilliporeSigma) supplemented with 0.034 g/l D-valine (MilliporeSigma), 10% FBS (Biowest LLC) and 10% horse serum (Gibco; Thermo Fisher Scientific, Inc.) in an environment containing 5% CO2 at 37˚C. HKL (purity, ≥98%) was purchased from Shanghai Aladdin Biochemical Technology Co., Ltd., where its structural formula is shown in Fig. 1A.

Honokiol treatment improves the viability of LPS-treated bEECs. (A) Chemical structural formula of HKL. (B) The viability of bEECs following treatment with different doses of HKL as detected by MTT. (C) The viability of LPS-stimulated bEECs following treatment with different doses of HKL as detected by MTT. **P<0.01 and ***P<0.001 vs. Control; ##P<0.01 vs. LPS. HKL or Hon, honokiol; LPS, lipopolysaccharide; bEECs, bovine endometrial epithelial cells.

Pre-treatment of the cells was performed with HKL at doses of 1, 10 and 20 µM for 1 h at 37˚C, followed by stimulation with 1 µg/ml LPS for 12 h at 37˚C. In addition, 1 µg/ml Tunicamycin (an ER stress inducer; purchased from MedChemExpress), was added into cells for 2 h at 37˚C followed by LPS treatment. Cells without any treatment were considered to be the control group.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A